Found 17792 matching trials
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE
PHASE4The objectives of the study were:
1. To assess the safety and tolerability...
Location
Allergy, Asthma and Immunology Associates
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)
PHASE1Primary trial objective in this single arm trial is to assess the safety an...
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Radiation Therapy in Unresectable Gall Bladder Cancer
PHASE2The goal of this clinical trial is to compare two treatment regimes, namely...
Location
Tata Memorial Centre
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
PHASE1This is a pilot, explorative, study to test the feasibility and safety of s...
Location
Unit of Oncology - Ospedali Riuniti of Bergamo
Human Upper Extremity Allotransplantation
PHASE2Background: Millions of people each year sustain injuries, have tumors surg...
Location
Johns Hopkins University School of Medicine
A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis
PHASE2The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
PHASE1Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Location
Chinese PLA General Hospital
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy
PHASE2The trial is designed as a multi-center, open label Phase 2 trial that inve...
Location
3203; Antwerp University Hospital; Department of Medical Oncology
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas
PHASE1This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Location
Multiple Locations